FDA Rejects the Psychedelic MDMA as a PTSD Treatment TIMEsource Post navigation FDA rejects psychedelic drug therapy for PTSD – Washington TimesTryptamine Therapeutics’ Psilocybin Trial Shows Promising Results – TipRanks
